Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT05348213 · RECRUITING
Trial details
- NCT number
- NCT05348213
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2025-06-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.